AGEN
HEALTHCAREAgenus Inc
$3.89-0.28 (-6.71%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving AGEN Today?
No stock-specific AI insight has been generated for AGEN yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$2.71$7.34
$3.89
Fundamentals
Market Cap$162M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE-12.8%
Profit Margin0.0%
Debt / Equity—
Trading
Volume1.5M
Avg Volume (10D)—
Shares Outstanding41.5M
AGEN News
20 articles- VRTX's Alyftrek, Journavx & Casgevy See Strong Momentum in Q1 EarningsYahoo Finance·May 8, 2026
- Viatris Q1 EPS Beats Estimates, Revenues up 8% Driven by Greater ChinaYahoo Finance·May 7, 2026
- ADMA Q1 EPS Jumps 73% Y/Y, Revenues Slip, 2026 View DownYahoo Finance·May 7, 2026
- TGTX Q1 Earnings Miss, Sales Rise Y/Y, Stock Up on Raised 2026 ViewYahoo Finance·May 7, 2026
- Mirum's Q1 Earnings & Revenues Beat Estimates, 2026 View RaisedYahoo Finance·May 7, 2026
- Castle Biosciences, Inc. (CSTL) Reports Q1 Loss, Beats Revenue EstimatesYahoo Finance·May 6, 2026
- Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock RisesYahoo Finance·May 6, 2026
- Repligen's Q1 Earnings & Revenues Beat Estimates, Stock RisesYahoo Finance·May 6, 2026
- Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?Yahoo Finance·May 6, 2026
- VRTX's Q1 Earnings Beat Estimates, New Products Aid Sales GrowthYahoo Finance·May 5, 2026
- Are Options Traders Betting on a Big Move in Agenus Stock?Yahoo Finance·May 5, 2026
- Agenus to Provide First Quarter 2026 Financial Report and Corporate UpdateYahoo Finance·May 4, 2026
- Agenus (AGEN) Earnings Expected to Grow: What to Know Ahead of Q1 ReleaseYahoo Finance·May 4, 2026
- CORT Q1 Earnings Match Estimates, Revenues Miss, 2026 Outlook RaisedYahoo Finance·May 1, 2026
- Q32 Bio Gears Up to Report Q1 Earnings: What's in the Cards?Yahoo Finance·Apr 30, 2026
- Vertex Gears Up to Report Q1 Earnings: What Investors Can ExpectYahoo Finance·Apr 28, 2026
- CRISPR Therapeutics to Report Q1 Earnings: Is a Beat in the Cards?Yahoo Finance·Apr 27, 2026
- AMRX Announces Kashiv BioSciences Buyout, Solid Q1 Preliminary ResultsYahoo Finance·Apr 23, 2026
- Align Technology's Q1 Earnings on Deck: Here's What to ExpectYahoo Finance·Apr 21, 2026
- Agenus to Present First Phase 2 Botensilimab Data in Advanced Cutaneous Melanoma at ASCO 2026Yahoo Finance·Apr 21, 2026
All 20 articles loaded
Price Data
Open$4.06
Previous Close$4.17
Day High$4.27
Day Low$4.05
52 Week High$7.34
52 Week Low$2.71
52-Week Range
$2.71$7.34
$3.89
Fundamentals
Market Cap$162M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE-12.8%
Profit Margin0.0%
Debt / Equity—
Trading
Volume1.5M
Avg Volume (10D)—
Shares Outstanding41.5M
About Agenus Inc
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company is headquartered in Lexington, Massachusetts.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—